GM warns workers in Brazil on losses, tough turnaround plan

April 29 (Reuters) – Xvivo Perfusion AB:

* SAID ON SATURDAY RECEIVED MARKET APPROVAL (PMA) FROM FDA FOR STEEN SOLUTION AND XPS

* RECEIVES PREMARKET APPROVAL (PMA) FROM FDA FOR PRODUCTS XPS AND STEEN SOLUTION FOR SALE ON THE AMERICAN MARKET

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)



Source link